NFKB1 and breast carcinoma: Hamdoun and Efferth reported that 25 μM of ginkgolic acid C13:0 inhibited the migration in breast cancer cells through a mechanism of inhibiting the SUMOylation of NEMO (a key upstream regulator of NF-κB) and NF-κB activity [27].